世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

スタチン市場：世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測


Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

市場の概要 世界のスタチン市場規模は、2022年に149億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に3.2%の成長率（CAGR）を示し、2028年までに181億米ドルに達すると予測しています。 ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		147 英語

　

サマリー

市場の概要

世界のスタチン市場規模は、2022年に149億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に3.2%の成長率（CAGR）を示し、2028年までに181億米ドルに達すると予測しています。

スタチンとは、脂質低下薬の一つで、血中コレステロール値を下げるために患者さんが摂取する薬剤です。アトルバスタチン、ロスバスタチン、ロバスタチン、シンバスタチンは、市場で入手できる最も一般的なタイプのスタチンである。これらの薬は、動脈硬化や心臓発作の予防に役立ち、抗炎症作用やプラークを安定化させる効果が顕著です。また、血管の炎症と体内の酸化ストレスを最小限に抑える効果もあります。さらに、スタチンは肝臓でコレステロールを生成するのに重要な酵素の生成を阻害するため、体内の血中コレステロール値を全体的に低下させるのに役立ちます。

世界的に高コレステロール血症が増加していることは、市場の成長を促進する重要な要因の一つとなっています。この疾患は、老年人口や糖尿病、肥満、心血管疾患（CVD）などの他の疾患を患っている人の間で非常に多く、先進国および新興国の両方で製品の採用を促進しています。さらに、一般用医薬品に対する消費者の嗜好が高まっていることも、市場の成長に寄与しています。一般用医薬品は、先発医薬品と比較して、通常、より手頃な価格で購入することができます。さらに、スタチンとエゼチミブのようなコレステロールを減少させる化合物を併用する治療法の採用が増加していることも、成長を促進する要因となっています。スタチン-エゼチミブ併用療法は、家族性高コレステロール血症患者の脂質プロファイルを正常に近づけ、CVDの発生リスクを大幅に低減できることが研究で明らかになっています。その他、医療インフラの改善や消費者の健康意識の高まりなどが、市場をさらに牽引すると予測されます。

IMARC Groupの最新レポートは、世界のスタチン市場について、その本質的な側面をすべて網羅した深い洞察を提供します。その内容は、市場のマクロ的な概観から、業界実績のミクロ的な詳細、最近の動向、主要な市場促進要因と課題、SWOT分析、ポーターの5つの力分析、バリューチェーン分析などに及びます。本レポートは、業界関係者、投資家、研究者、コンサルタント、ビジネス戦略家、および何らかの形でスタチン業界に参入している、または参入を計画しているすべての人々にとって必読の書となります。

主要な市場セグメント：

IMARC Groupは、世界のスタチン市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、市場をタイプ、治療分野、薬物クラス、用途、分布に基づき分類しています。

タイプ別構成比：

合成スタチン
天然スタチン


治療領域別の内訳：

循環器疾患
肥満
炎症性疾患
その他

薬効分類別内訳：

アトルバスタチン
フルバスタチン
ロバスタチン
プラバスタチン
シンバスタチン
その他


アプリケーション別のブレークアップ：

脂質異常症（Dyslipidemia
その他


流通別の内訳：

ホスピタルズ
クリニック
その他


地域別構成比：

北アメリカ

ユーエスエー
カナダ


アジア太平洋

中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他


ヨーロッパ

ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他


ラテンアメリカ

ブラジル
メキシコ
その他


中近東・アフリカ


競合の状況：

また、業界の競争環境についても検討されており、主要なプレーヤーとして、Abbott Laboratories、AstraZeneca、Aurobindo Pharma、Biocon、GlaxoSmithKline、Merck & Co.、Novartis、Pfizer、などが挙げられています。

本レポートで回答した主な質問

世界のスタチン市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
COVID-19は世界のスタチン市場にどのような影響を与えているか？
主要な地域市場とは？
タイプに基づく市場の内訳は？
治療領域に基づく市場のブレークアップは？
薬効分類に基づく市場の内訳は？
アプリケーションに基づく市場のブレークアップは？
流通に基づく市場のブレークアップは？
業界のバリューチェーンにおける様々なステージは何か？
市場の主要な推進要因と課題は何か？
世界のスタチン市場の構造と主要プレイヤーは？
市場における競争の程度はどの程度か？



ページTOPに戻る


目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Statin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Synthetic Statins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Natural Statins
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Cardiovascular Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obesity
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inflammatory Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Drug Class
8.1 Atorvastatin
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fluvastatin
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lovastatin
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pravastatin
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Simvastatin
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Dyslipidemia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Others
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 France
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 United Kingdom
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 Italy
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Spain
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Russia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 Japan
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 India
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 South Korea
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Australia
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Indonesia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 AstraZeneca
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Aurobindo Pharma
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Biocon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 GlaxoSmithKline
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck & Co.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Novartis
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Pfizer
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis

List of Figures

Figure 1: Global: Statin Market: Major Drivers and Challenges
Figure 2: Global: Statin Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Statin Market: Breakup by Type (in %), 2022
Figure 4: Global: Statin Market: Breakup by Therapeutic Area (in %), 2022
Figure 5: Global: Statin Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: Statin Market: Breakup by Application (in %), 2022
Figure 7: Global: Statin Market: Breakup by Distribution (in %), 2022
Figure 8: Global: Statin Market: Breakup by Region (in %), 2022
Figure 9: Global: Statin Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: Statin (Synthetic Statins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Statin (Synthetic Statins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Statin (Natural Statins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Statin (Natural Statins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Statin (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Statin (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Statin (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Statin (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Statin (Inflammatory disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Statin (Inflammatory disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Statin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Statin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Statin (Atorvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Statin (Atorvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Statin (Fluvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Statin (Fluvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Statin (Lovastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Statin (Lovastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Statin (Pravastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Statin (Pravastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Statin (Simvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Statin (Simvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Statin (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Statin (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Statin (Dyslipidemia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Statin (Dyslipidemia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Statin (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Statin (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Statin (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Statin (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Statin (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Statin (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Statin (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Statin (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: North America: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: North America: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: United States: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: United States: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Canada: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Canada: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Asia Pacific: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Asia Pacific: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: China: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: China: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Japan: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Japan: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: India: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: India: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: South Korea: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: South Korea: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Australia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Australia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Indonesia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Indonesia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Europe: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Europe: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Germany: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Germany: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: France: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: France: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: United Kingdom: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: United Kingdom: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Italy: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Italy: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Spain: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Spain: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Russia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Russia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Latin America: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Latin America: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Brazil: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Brazil: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Mexico: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Mexico: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Middle East and Africa: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Middle East and Africa: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Statin Industry: SWOT Analysis
Figure 93: Global: Statin Industry: Value Chain Analysis
Figure 94: Global: Statin Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Statin Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Statin Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Statin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 4: Global: Statin Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 5: Global: Statin Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Statin Market Forecast: Breakup by Distribution (in Million US$), 2023-2028
Table 7: Global: Statin Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Statin Market: Competitive Structure
Table 9: Global: Statin Market: Key Players

　

ページTOPに戻る


　

Summary

Market Overview:

The global statin market size reached US$ 14.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028.

Statin is a lipid-lowering medication, an agent that is consumed by patients to reduce their blood cholesterol levels. Atorvastatin, rosuvastatin, lovastatin and simvastatin are the most common types of statins available in the market. They aid in preventing the instances of atherosclerosis and heart attacks and have significant anti-inflammatory and plaque-stabilizing effects. These drugs also aid in minimizing vascular inflammation and oxidative stress in the body. Besides this, statin interferes with the production of enzymes that are crucial for the liver to produce cholesterol, thus aiding in lowering the overall blood cholesterol levels in the body.

The increasing prevalence of hypercholesterolemia across the globe is among the key factors driving the growth of the market. This disorder is highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, obesity and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, increasing consumer preference for over-the-counter (OTC) drugs is another factor contributing to the market growth. In comparison to brand name drugs, OTC variants are usually more affordable. Additionally, the growing adoption of combination therapies that use statin with other cholesterol diminishing compounds, such as ezetimibe, is acting as another growth-inducing factor. Research has found statin-ezetimibe combination therapy to be capable of achieving near-normal lipid profiles in familial hypercholesterolemia patients and significantly reducing the risk of CVDs occurrence. Other factors, including improving healthcare infrastructure and growing health consciousness among consumers, are projected to drive the market further.

IMARC Group’s latest report provides a deep insight into the global statin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the statin industry in any manner.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global statin market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, therapeutic area, drug class, application and distribution.

Breakup by Type:

Synthetic Statins
Natural Statins


Breakup by Therapeutic Area:

Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others

Breakup by Drug Class:

Atorvastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others


Breakup by Application:

Dyslipidemia
Others


Breakup by Distribution:

Hospitals
Clinics
Others


Breakup by Region:

North America

United States
Canada


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, AstraZeneca, Aurobindo Pharma, Biocon, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, etc.

Key Questions Answered in This Report:

How has the global statin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global statin market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the market?
What is the structure of the global statin market and who are the key players?
What is the degree of competition in the market?



ページTOPに戻る


Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Statin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Synthetic Statins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Natural Statins
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapeutic Area
7.1 Cardiovascular Disorders
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obesity
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inflammatory Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Drug Class
8.1 Atorvastatin
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fluvastatin
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Lovastatin
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pravastatin
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Simvastatin
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Dyslipidemia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Others
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Distribution
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Europe
11.2.1 Germany
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 France
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 United Kingdom
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 Italy
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Spain
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Russia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Asia Pacific
11.3.1 China
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 Japan
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 India
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 South Korea
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Australia
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Indonesia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 AstraZeneca
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Aurobindo Pharma
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Biocon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 GlaxoSmithKline
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck & Co.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Novartis
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Pfizer
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis

List of Figures

Figure 1: Global: Statin Market: Major Drivers and Challenges
Figure 2: Global: Statin Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Statin Market: Breakup by Type (in %), 2022
Figure 4: Global: Statin Market: Breakup by Therapeutic Area (in %), 2022
Figure 5: Global: Statin Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: Statin Market: Breakup by Application (in %), 2022
Figure 7: Global: Statin Market: Breakup by Distribution (in %), 2022
Figure 8: Global: Statin Market: Breakup by Region (in %), 2022
Figure 9: Global: Statin Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 10: Global: Statin (Synthetic Statins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Statin (Synthetic Statins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Statin (Natural Statins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Statin (Natural Statins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Statin (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Statin (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Statin (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Statin (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Statin (Inflammatory disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Statin (Inflammatory disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Statin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Statin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Statin (Atorvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Statin (Atorvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Statin (Fluvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Statin (Fluvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Statin (Lovastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Statin (Lovastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Statin (Pravastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Statin (Pravastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Statin (Simvastatin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Statin (Simvastatin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Statin (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Statin (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Statin (Dyslipidemia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Statin (Dyslipidemia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Statin (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Statin (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Statin (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Statin (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Statin (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Statin (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Statin (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Statin (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: North America: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: North America: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: United States: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: United States: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Canada: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Canada: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Asia Pacific: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Asia Pacific: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: China: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: China: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Japan: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Japan: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: India: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: India: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: South Korea: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: South Korea: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Australia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Australia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Indonesia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Indonesia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Europe: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Europe: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Germany: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Germany: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: France: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: France: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: United Kingdom: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: United Kingdom: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Italy: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Italy: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Spain: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Spain: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Russia: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Russia: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Latin America: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Latin America: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Brazil: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Brazil: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Mexico: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Mexico: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Middle East and Africa: Statin Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Middle East and Africa: Statin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Global: Statin Industry: SWOT Analysis
Figure 93: Global: Statin Industry: Value Chain Analysis
Figure 94: Global: Statin Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Statin Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Statin Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Statin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 4: Global: Statin Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 5: Global: Statin Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Statin Market Forecast: Breakup by Distribution (in Million US$), 2023-2028
Table 7: Global: Statin Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Statin Market: Competitive Structure
Table 9: Global: Statin Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.